Systemic metabolic parameters
Weight (g) | Blood glucose (mg/dL) | ||||
---|---|---|---|---|---|
Diabetes duration | Experimental condition | n | Final | Before treatment | Final |
STZ rats | |||||
4 weeks | CONTROL | 8 | 400 ± 9 | 127 ± 14 | 113 ± 8 |
DIABETIC | 8 | 275 ± 14 | 501 ± 31 | 463 ± 18 | |
DIABETIC + LOC INS | 8 | 282 ± 13 | 490 ± 38 | 465 ± 13 | |
DIABETIC + PHL | 8 | 282 ± 13 | 492 ± 27 | 237 ± 45 | |
DIABETIC + PHL + LOC INS | 8 | 259 ± 6 | 555 ± 19 | 155 ± 8 | |
DIABETIC + SYS INS | 7 | 326 ± 8 | 448 ± 13 | 222 ± 13 | |
8 weeks | CONTROL | 8 | 475 ± 13 | 154 ± 19 | 140 ± 18 |
DIABETIC | 8 | 260 ± 9 | 478 ± 30 | 512 ± 29 | |
DIABETIC + LOC INS | 7 | 314 ± 22 | 535 ± 34 | 468 ± 25 | |
DIABETIC + PHL | 9 | 291 ± 21 | 536 ± 27 | 174 ± 18 | |
DIABETIC + PHL + LOC INS | 10 | 271 ± 13 | 486 ± 33 | 220 ± 19 | |
DIABETIC + SYS INS | 16 | 365 ± 10 | 526 ± 13 | 174 ± 29 | |
12 weeks | CONTROL | 8 | 564 ± 19 | 116 ± 5 | 105 ± 2 |
DIABETIC | 8 | 302 ± 17 | 453 ± 34 | 425 ± 25 | |
DIABETIC + LOC INS | 9 | 305 ± 24 | 477 ± 27 | 418 ± 30 | |
DIABETIC + PHL | 6 | 294 ± 20 | 461 ± 25 | 236 ± 22 | |
DIABETIC + PHL + LOC INS | 8 | 320 ± 22 | 412 ± 28 | 178 ± 19 | |
DIABETIC + SYS INS | 9 | 460 ± 9 | 456 ± 26 | 209 ± 29 | |
Ins2Akita mice | |||||
4 weeks | CONTROL | 10 | 21.2 ± 0.3 | N/A | 180 ± 8 |
DIABETIC | 10 | 21.6 ± 0.7 | N/A | 209 ± 32 | |
8 weeks | CONTROL | 9 | 29.4 ± 0.8 | N/A | 165 ± 12 |
DIABETIC | 11 | 26.0 ± 0.5 | N/A | 450 ± 37 | |
12 weeks | CONTROL | 9 | 29.6 ± 0.9 | N/A | 177 ± 6 |
DIABETIC | 10 | 25.8 ± 0.6 | N/A | 545 ± 16 |
Data are mean ± SEM. LOC INS, local insulin; N/A, not applicable; PHL, phloridzin; SYS INS, systemic insulin.